Over the past two decades, human immunodeficiency virus type 1 has placed an enormous socioeconomic burden on the global population. The ultimate ambition of HIV-1 research is to eradicate the virus from infected individuals and devise strategies to limit its spread amongst the human population. Unfortunately, this arduous ambition may be further complicated by the fact that HIV-1 appears to target the central nervous system (CNS) early after peripheral infection, giving rise to unwieldy neurologic complications in 30-60% of patients. HIV-1 also has the capacity to cripple the immune system and open the floodgates for opportunistic secondary infections that can also seek refuge in the immunologically specialized CNS. Because the CNS is fraught with mechanisms to limit the toxicity (and likely the effectiveness) of an immune response, it often provides a favorable environment for persistent pathogens. Consequently, once a pathogen establishes persistence in the CNS, it may become far more challenging to purge the pathogen from this compartment than peripheral tissues. Thus, even if researchers accomplish the monumental task of attaining sterilizing immunity in peripheral tissues, it is likely that HIV-1 and/or other opportunistic infections will continue to persist in the CNS and contribute to neurologic abnormalities. The proposed study will explore a novel murine model of CNS viral persistence to address whether it is possible for the host immune response to purge an infection once it has established persistence in the CNS. Contemporary T cell tracking methodologies will be utilized to monitor the migration and interactions of virus-specific T cells in the CNS following reactivation in the periphery (a scenario that we hope to achieve in humans). The proposed study will also explore adoptive immunotherapy as a strategy to assist the endogenous host response in its pursuit to eliminate persistently infected CNS cells. The main objective of this research is to define the immunologic parameters that contribute to viral clearance versus persistence in the CNS and foster approaches that tip the balance in favor of clearance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS048866-02
Application #
6906373
Study Section
Special Emphasis Panel (ZRG1-CNBT (01))
Program Officer
Nunn, Michael
Project Start
2004-06-15
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2007-05-31
Support Year
2
Fiscal Year
2005
Total Cost
$260,434
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Truong, Phi; McGavern, Dorian B (2008) A novel virus carrier state to evaluate immunotherapeutic regimens: regulatory T cells modulate the pathogenicity of antiviral memory cells. J Immunol 181:1161-9
Brooks, David G; Lee, Andrew M; Elsaesser, Heidi et al. (2008) IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med 205:533-41
Lauterbach, Henning; Truong, Phi; McGavern, Dorian B (2007) Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification. Virol J 4:53
Brooks, David G; McGavern, Dorian B; Oldstone, Michael B A (2006) Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest 116:1675-85
Kunz, Stefan; Rojek, Jillian M; Roberts, Amanda J et al. (2006) Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus. J Virol 80:9082-92
Tishon, Antoinette; Lewicki, Hanna; Andaya, Abegail et al. (2006) CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. Virology 347:234-45
Brooks, David G; Trifilo, Matthew J; Edelmann, Kurt H et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12:1301-9
Lauterbach, Henning; Zuniga, Elina I; Truong, Phi et al. (2006) Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. J Exp Med 203:1963-75
McGavern, Dorian B (2005) The role of bystander T cells in CNS pathology and pathogen clearance. Crit Rev Immunol 25:289-303
Giorgi, Filippo S; Malhotra, Samit; Hasson, Henry et al. (2005) Effects of status epilepticus early in life on susceptibility to ischemic injury in adulthood. Epilepsia 46:490-8

Showing the most recent 10 out of 12 publications